In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Capivasertib in combination with Faslodex is indicated for the treatment of adul···【more】
Release date:2026-01-13Recommended:161
Capivasertib, in combination with Fulvestrant, is indicated for the treatment of···【more】
Release date:2026-01-13Recommended:148
Capivasertib belongs to a class of medications known as antineoplastic agents. I···【more】
Release date:2026-01-13Recommended:175
On November 17, 2023, AstraZeneca’s capivasertib in combination with Faslodex (f···【more】
Release date:2026-01-13Recommended:182
On June 12, 2023, the New Drug Application (NDA) for capivasertib in combination···【more】
Release date:2026-01-13Recommended:155
Capmatinib slows down or inhibits the spread of cancer cells by blocking a key p···【more】
Release date:2026-01-09Recommended:154
The mechanism of action of capmatinib lies in targeting and blocking the specifi···【more】
Release date:2026-01-09Recommended:164
Camatinib is indicated for the treatment of specific types of non-small cell lun···【more】
Release date:2026-01-09Recommended:167
During treatment with capmatinib, your doctor will need to regularly monitor you···【more】
Release date:2026-01-09Recommended:176
Capmatinib may make your skin more sensitive to sunlight, sunlamps, and tanning ···【more】
Release date:2026-01-09Recommended:138
Common side effects include fluid retention, nausea, vomiting, myalgia, fatigue,···【more】
Release date:2026-01-09Recommended:153
Capmatinib inhibits c-Met, a type of tyrosine kinase that plays a role in embryo···【more】
Release date:2026-01-09Recommended:129